文献速递儿童呼吸儿童感染

儿童社区获得性肺炎抗生素处方的差异性

Variability in Antibiotic Prescribing for Community-Acquired Pneumonia.
PubMed 文献 · Pediatrics · 2017-03-07

非临床因素如郊区诊所和私人保险显著影响抗生素选择,提示需针对性开展抗菌药物管理。

要点

  • 多数CAP患儿未接受指南推荐的阿莫西林,大环内酯类和广谱抗生素使用比例高。
  • 年龄≥5岁、既往抗生素使用和私人保险与大环内酯类处方增加相关。
  • 郊区诊所和私人保险与广谱抗生素处方增加相关,提示非临床因素驱动处方差异。

核心结论

  • CAP抗生素选择在诊所间差异很大,且与微生物学病因无关的因素显著驱动处方选择。

主要发现

  • 4239例(40.7%)接受阿莫西林,4430例(42.5%)接受大环内酯类,1745例(16.8%)接受广谱抗生素。
  • 与阿莫西林相比,大环内酯类处方的增加与年龄≥5岁(aOR 6.18;95%CI 5.53-6.91)、既往抗生素使用(aOR 1.79;95%CI 1.56-2.04)和私人保险(aOR 1.47;95%CI 1.28-1.70)相关。
  • 广谱抗生素处方的增加与郊区诊所(aOR 7.50;95%CI 4.16-13.55)和私人保险(aOR 1.42;95%CI 1.18-1.71)相关。
  • 各诊所间大环内酯类处方的预测概率范围为0.22至0.83。

临床怎么用

  • 临床医生应关注非临床因素对CAP抗生素选择的影响,促进遵循指南推荐使用阿莫西林。
  • 抗菌药物管理项目可针对高处方变异诊所和特定患者特征进行干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Published guidelines recommend amoxicillin for most children with community-acquired pneumonia (CAP), yet macrolides and broad-spectrum antibiotics are more commonly prescribed. We aimed to determine the patient and clinician characteristics associated with the prescription of amoxicillin versus macrolide or broad-spectrum antibiotics for CAP. METHODS: Retrospective cohort study in an outpatient pediatric primary care network from July 1, 2009 to June 30, 2013. Patients prescribed amoxicillin, macrolides, or a broad-spectrum antibiotic (amoxicillin-clavulanic acid, cephalosporin, or fluoroquinolone) for CAP were included. Multivariable logistic regression models were implemented to identify predictors of antibiotic choice for CAP based on patient- and clinician-level characteristics, controlling for practice. RESULTS: Of 10 414 children, 4239 (40.7%) received amoxicillin, 4430 (42.5%) received macrolides and 1745 (16.8%) received broad-spectrum antibiotics. The factors associated with an increased odds of receipt of macrolides compared with amoxicillin included patient age ≥5 years (adjusted odds ratio [aOR]: 6.18; 95% confidence interval [CI]: 5.53-6.91), previous antibiotic receipt (aOR: 1.79; 95% CI: 1.56-2.04), and private insurance (aOR: 1.47; 95% CI: 1.28-1.70). The predicted probability of a child being prescribed a macrolide ranged significantly between 0.22 and 0.83 across clinics. The nonclinical characteristics associated with an increased odds of receipt of broad-spectrum antibiotics compared with amoxicillin included suburban practice (aOR: 7.50; 95% CI: 4.16-13.55) and private insurance (aOR: 1.42; 95% CI: 1.18-1.71). CONCLUSIONS: Antibiotic choice for CAP varied widely across practices. Factors unlikely related to the microbiologic etiology of CAP were significant drivers of antibiotic choice. Understanding drivers of off-guideline prescribing can inform targeted antimicrobial stewardship initiatives.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Handy LK, Bryan M, Gerber JS, et al. Variability in Antibiotic Prescribing for Community-Acquired Pneumonia. Pediatrics. 2017. PMID: 28270546. doi:10.1542/peds.2016-2331

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。